United Kingdom

People: Sinopharm Group Co Ltd (1099.HK)

1099.HK on Hong Kong Stock

16 Aug 2019
Change (% chg)

HK$0.60 (+2.29%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Li, Ling 

Ms. Li Ling is an Independent Non-Executive Director of Sinopharm Group Co. Ltd. Ms. Li joined the Group on 29 December 2012, and has been an independent not-executive Director since then. Ms. Li has around 35 years of working experience. She obtained a bachelor’s degree in physics in August 1982 and a master’s degree in economics in February 1987 from Wuhan University, and obtained a master’s degree and a doctorate degree in economics from University of Pittsburgh in U.S.A in September 1990 and May 1994, respectively. Ms. Li worked at the Department of Economics of Towson University in Maryland, U.S.A as an associate professor with tenure from August 2000 to August 2003, and also taught at the Department of Economics of University of Pittsburgh in U.S.A and the Department of Management and Marketing of The Hong Kong Polytechnic University. Ms. Li has been an economics professor and Ph.D. supervisor at Research Institute of National Development, a director of Research Center of China Healthy Development of Peking University since June 2008, and is an expert who enjoys the special allowance of the State Council and is one of the “Top Ten Teachers” of Peking University. Ms. Li has served as an independent director of PICC Health Insurance Company Limited since 2009. Ms. Li currently also serves as the vice chairman of China Health Economics Association, a member of the State Council Health Reform Advisory Commission, a member of National Health and Family Planning Commission on public policy, an evaluation expert in the Pilot Project of Urban Resident Basic Medical Insurance implemented by the State Council, an advisor to the Beijing Municipal Government, an advisor to the pharmaceutical and healthcare reform of Guangdong Province and the vice chairman of Gerontological Society of China.

Basic Compensation

Total Annual Compensation, CNY 300,000
Restricted Stock Award, CNY --
Long-Term Incentive Plans, CNY --
All Other, CNY --
Fiscal Year Total, CNY 300,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Zhiming Li


Yong Liu


Qiyu Chen


Xiuchang Jiang


Maisong Cai


Jun Lu

As Of  31 Dec 2017